Abstract
To evaluate alterations induced by injected murine radiolabelled F(ab')2 fragments of the anti HMW-MAA MoAb 225.28S on the principal haemato-immunological parameters, 32 patients with advanced malignant melanoma were studied. No statistically significant change was found after MoAb administration, but monocytes (3 h after injection) and granular eosinophils (24 h after) were reduced and circulating immune complexes increased (3 h after). No toxic effect or adverse reaction was observed. Therefore, the controlled administration of purified MoAb fragments for diagnostic purposes seems to involve only a very low risk of immediate adverse reactions.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Animals
-
Antibodies, Monoclonal / immunology
-
Antigen-Antibody Complex / analysis
-
Antigens, Neoplasm
-
Biomarkers, Tumor / immunology*
-
Blood Cell Count
-
Female
-
Humans
-
Immunoglobulin Fab Fragments / administration & dosage*
-
Injections, Intravenous
-
Male
-
Melanoma / blood
-
Melanoma / diagnosis
-
Melanoma / immunology*
-
Melanoma-Specific Antigens
-
Mice
-
Middle Aged
-
Neoplasm Proteins / immunology*
-
Technetium
Substances
-
Antibodies, Monoclonal
-
Antigen-Antibody Complex
-
Antigens, Neoplasm
-
Biomarkers, Tumor
-
Immunoglobulin Fab Fragments
-
Melanoma-Specific Antigens
-
Neoplasm Proteins
-
Technetium